Colombia To Lower Price Of Novartis Cancer Drug Gleevec
The Colombian government announced on Thursday that it will expedite a declaration of public interest concerning a Novartis cancer drug that will allow it to reduce its price....To view the full article, register now.
Already a subscriber? Click here to view full article